{"count":221415,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=367","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=365","results":[{"created":"2024-10-10T17:56:20.838594+11:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"1.286","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: UFC1: Changed phenotypes: Neurodevelopmental disorder with spasticity and poor growth (MIM#618076)","entity_name":"UFC1","entity_type":"gene"},{"created":"2024-10-10T17:56:14.839615+11:00","panel_name":"Microcephaly","panel_id":138,"panel_version":"1.286","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: UFC1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"UFC1","entity_type":"gene"},{"created":"2024-10-10T17:55:55.178756+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.2063","user_name":"Zornitza Stark","item_type":"entity","text":"Tag deep intronic tag was added to gene: UFC1.","entity_name":"UFC1","entity_type":"gene"},{"created":"2024-10-10T17:55:39.590264+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.2063","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: UFC1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Neurodevelopmental disorder with spasticity and poor growth (MIM#618076); Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"UFC1","entity_type":"gene"},{"created":"2024-10-10T11:49:57.538279+11:00","panel_name":"Prepair 1000+","panel_id":3861,"panel_version":"1.390","user_name":"Crystle Lee","item_type":"entity","text":"reviewed gene: CLPB: Rating: GREEN; Mode of pathogenicity: None; Publications: 34140661; Phenotypes: 3-methylglutaconic aciduria, type VIIB, autosomal recessive (MIM#616271); Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CLPB","entity_type":"gene"},{"created":"2024-10-10T08:53:27.850304+11:00","panel_name":"Motor Neurone Disease","panel_id":25,"panel_version":"1.24","user_name":"Bryony Thompson","item_type":"entity","text":"Tag treatable tag was added to gene: SOD1.","entity_name":"SOD1","entity_type":"gene"},{"created":"2024-10-09T19:02:33.761018+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6489","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: RPS6KA3 as ready","entity_name":"RPS6KA3","entity_type":"gene"},{"created":"2024-10-09T19:02:33.739021+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6489","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rps6ka3 has been classified as Green List (High Evidence).","entity_name":"RPS6KA3","entity_type":"gene"},{"created":"2024-10-09T19:02:26.551443+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6489","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: RPS6KA3 were changed from  to Coffin-Lowry syndrome MIM# 303600","entity_name":"RPS6KA3","entity_type":"gene"},{"created":"2024-10-09T19:01:46.630142+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6488","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: RPS6KA3 was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"RPS6KA3","entity_type":"gene"},{"created":"2024-10-09T19:01:09.959303+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6487","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: RPS6KA3: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Coffin-Lowry syndrome MIM# 303600; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"RPS6KA3","entity_type":"gene"},{"created":"2024-10-09T19:00:11.475128+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6487","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: RPGRIP1L as ready","entity_name":"RPGRIP1L","entity_type":"gene"},{"created":"2024-10-09T19:00:11.433806+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6487","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rpgrip1l has been classified as Green List (High Evidence).","entity_name":"RPGRIP1L","entity_type":"gene"},{"created":"2024-10-09T19:00:04.196273+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6487","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: RPGRIP1L were changed from  to Joubert syndrome 7, MIM# 611560; Meckel syndrome 5, MIM# 611561","entity_name":"RPGRIP1L","entity_type":"gene"},{"created":"2024-10-09T18:59:22.508589+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6486","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: RPGRIP1L was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"RPGRIP1L","entity_type":"gene"},{"created":"2024-10-09T18:58:44.250986+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6485","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: RPGRIP1L: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Joubert syndrome 7, MIM# 611560, Meckel syndrome 5, MIM# 611561; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"RPGRIP1L","entity_type":"gene"},{"created":"2024-10-09T18:54:42.630009+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6485","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: RNASET2 as ready","entity_name":"RNASET2","entity_type":"gene"},{"created":"2024-10-09T18:54:42.610123+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6485","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rnaset2 has been classified as Green List (High Evidence).","entity_name":"RNASET2","entity_type":"gene"},{"created":"2024-10-09T18:54:36.990678+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6485","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: RNASET2 were changed from  to Leukoencephalopathy, cystic, without megalencephaly, MIM# 612951","entity_name":"RNASET2","entity_type":"gene"},{"created":"2024-10-09T18:53:49.292574+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6484","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: RNASET2 were set to ","entity_name":"RNASET2","entity_type":"gene"},{"created":"2024-10-09T18:53:10.571540+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6483","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: RNASET2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"RNASET2","entity_type":"gene"},{"created":"2024-10-09T18:49:10.187193+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6482","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: RNASET2: Added comment: More than 10 families reported, DD/ID is part of the phenotype.; Changed publications: 31349848, 19525954, 27091087, 29336640, 18545798, 15851732","entity_name":"RNASET2","entity_type":"gene"},{"created":"2024-10-09T18:48:15.938084+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6482","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: RNASET2: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Leukoencephalopathy, cystic, without megalencephaly, MIM# 612951; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"RNASET2","entity_type":"gene"},{"created":"2024-10-09T18:47:31.745402+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6482","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: RNASEH2C as ready","entity_name":"RNASEH2C","entity_type":"gene"},{"created":"2024-10-09T18:47:31.731837+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6482","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rnaseh2c has been classified as Green List (High Evidence).","entity_name":"RNASEH2C","entity_type":"gene"},{"created":"2024-10-09T18:47:22.955586+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6482","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: RNASEH2C were changed from  to Aicardi-Goutieres syndrome 3, MIM# 610329","entity_name":"RNASEH2C","entity_type":"gene"},{"created":"2024-10-09T18:46:00.245606+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6481","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: RNASEH2C was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"RNASEH2C","entity_type":"gene"},{"created":"2024-10-09T18:45:11.316667+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6480","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: RNASEH2C: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Aicardi-Goutieres syndrome 3, MIM# 610329; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"RNASEH2C","entity_type":"gene"},{"created":"2024-10-09T18:44:21.787783+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6480","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: RNASEH2B as ready","entity_name":"RNASEH2B","entity_type":"gene"},{"created":"2024-10-09T18:44:21.770988+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6480","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rnaseh2b has been classified as Green List (High Evidence).","entity_name":"RNASEH2B","entity_type":"gene"},{"created":"2024-10-09T18:44:04.558415+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6480","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: RNASEH2B were changed from  to Aicardi-Goutieres syndrome 2, MIM# 610181","entity_name":"RNASEH2B","entity_type":"gene"},{"created":"2024-10-09T18:43:21.187258+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6479","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: RNASEH2B was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"RNASEH2B","entity_type":"gene"},{"created":"2024-10-09T18:42:42.506152+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6478","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: RNASEH2B: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Aicardi-Goutieres syndrome 2, MIM# 610181; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"RNASEH2B","entity_type":"gene"},{"created":"2024-10-09T18:41:35.690062+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6478","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: RNASEH2A as ready","entity_name":"RNASEH2A","entity_type":"gene"},{"created":"2024-10-09T18:41:35.676210+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6478","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rnaseh2a has been classified as Green List (High Evidence).","entity_name":"RNASEH2A","entity_type":"gene"},{"created":"2024-10-09T18:33:20.251329+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6478","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: RNASEH2A were changed from  to Aicardi-Goutieres syndrome 4, MIM# 610333","entity_name":"RNASEH2A","entity_type":"gene"},{"created":"2024-10-09T18:32:41.519868+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6477","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: RNASEH2A was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"RNASEH2A","entity_type":"gene"},{"created":"2024-10-09T18:32:03.516044+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6476","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: RNASEH2A: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Aicardi-Goutieres syndrome 4, MIM# 610333; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"RNASEH2A","entity_type":"gene"},{"created":"2024-10-09T18:31:15.389152+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6476","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: RMND1 as ready","entity_name":"RMND1","entity_type":"gene"},{"created":"2024-10-09T18:31:15.355367+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6476","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rmnd1 has been classified as Green List (High Evidence).","entity_name":"RMND1","entity_type":"gene"},{"created":"2024-10-09T18:31:10.745821+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6476","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: RMND1 were changed from  to Combined oxidative phosphorylation deficiency 11 MIM#614922","entity_name":"RMND1","entity_type":"gene"},{"created":"2024-10-09T18:30:31.505435+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6475","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: RMND1 were set to ","entity_name":"RMND1","entity_type":"gene"},{"created":"2024-10-09T18:29:53.678509+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6474","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: RMND1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"RMND1","entity_type":"gene"},{"created":"2024-10-09T18:29:19.571437+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6473","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: RMND1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Combined oxidative phosphorylation deficiency 11 MIM#614922; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"RMND1","entity_type":"gene"},{"created":"2024-10-09T18:28:27.213338+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6473","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: RIT1 as ready","entity_name":"RIT1","entity_type":"gene"},{"created":"2024-10-09T18:28:27.196527+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6473","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rit1 has been classified as Green List (High Evidence).","entity_name":"RIT1","entity_type":"gene"},{"created":"2024-10-09T18:28:12.201456+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6473","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: RIT1 were changed from  to Noonan syndrome 8, MIM# 615355","entity_name":"RIT1","entity_type":"gene"},{"created":"2024-10-09T18:27:13.230937+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6472","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: RIT1 were set to ","entity_name":"RIT1","entity_type":"gene"},{"created":"2024-10-09T18:26:26.774310+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6471","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of pathogenicity for gene: RIT1 was changed from  to Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments","entity_name":"RIT1","entity_type":"gene"},{"created":"2024-10-09T18:25:52.214217+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6470","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: RIT1 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"RIT1","entity_type":"gene"},{"created":"2024-10-09T18:24:55.062176+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6469","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: RFC4 as ready","entity_name":"RFC4","entity_type":"gene"},{"created":"2024-10-09T18:24:55.045178+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6469","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rfc4 has been classified as Green List (High Evidence).","entity_name":"RFC4","entity_type":"gene"},{"created":"2024-10-09T18:24:50.582040+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6469","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: RFC4 were changed from RFC4-related multisystem disorder to Neurodevelopmental disorder, MONDO:0700092, RFC4-related","entity_name":"RFC4","entity_type":"gene"},{"created":"2024-10-09T18:24:03.128068+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6468","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: RFC4: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Neurodevelopmental disorder, MONDO:0700092, RFC4-related; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"RFC4","entity_type":"gene"},{"created":"2024-10-09T18:21:11.884231+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6468","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: RARS2 as ready","entity_name":"RARS2","entity_type":"gene"},{"created":"2024-10-09T18:21:11.871737+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6468","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rars2 has been classified as Green List (High Evidence).","entity_name":"RARS2","entity_type":"gene"},{"created":"2024-10-09T18:17:05.091089+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6468","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: RARS2 were changed from  to Pontocerebellar hypoplasia, type 6, MIM# 611523","entity_name":"RARS2","entity_type":"gene"},{"created":"2024-10-09T18:13:55.480424+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6467","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: RARS2 were set to ","entity_name":"RARS2","entity_type":"gene"},{"created":"2024-10-09T18:07:48.321977+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6466","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: RARS2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"RARS2","entity_type":"gene"},{"created":"2024-10-09T18:07:00.545391+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.6465","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: RARS2: Rating: GREEN; Mode of pathogenicity: None; Publications: 17847012, 20635367, 25809939; Phenotypes: Pontocerebellar hypoplasia, type 6, MIM# 611523; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"RARS2","entity_type":"gene"},{"created":"2024-10-09T14:42:18.475432+11:00","panel_name":"Parathyroid Cancer","panel_id":4363,"panel_version":"1.0","user_name":"Zornitza Stark","item_type":"panel","text":"promoted panel to version 1.0","entity_name":null,"entity_type":null},{"created":"2024-10-09T14:42:09.479049+11:00","panel_name":"Parathyroid Cancer","panel_id":4363,"panel_version":"0.14","user_name":"Zornitza Stark","item_type":"panel","text":"Panel status changed from internal to public","entity_name":null,"entity_type":null},{"created":"2024-10-09T14:41:47.712001+11:00","panel_name":"Pituitary Tumour","panel_id":4364,"panel_version":"1.0","user_name":"Zornitza Stark","item_type":"panel","text":"promoted panel to version 1.0","entity_name":null,"entity_type":null},{"created":"2024-10-09T14:41:05.495421+11:00","panel_name":"Pituitary Tumour","panel_id":4364,"panel_version":"0.20","user_name":"Zornitza Stark","item_type":"panel","text":"Panel status changed from internal to public","entity_name":null,"entity_type":null},{"created":"2024-10-09T14:40:54.248646+11:00","panel_name":"Pituitary Tumour","panel_id":4364,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SDHD as ready","entity_name":"SDHD","entity_type":"gene"},{"created":"2024-10-09T14:40:54.232087+11:00","panel_name":"Pituitary Tumour","panel_id":4364,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: sdhd has been classified as Green List (High Evidence).","entity_name":"SDHD","entity_type":"gene"},{"created":"2024-10-09T14:40:47.473434+11:00","panel_name":"Pituitary Tumour","panel_id":4364,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SDHC as ready","entity_name":"SDHC","entity_type":"gene"},{"created":"2024-10-09T14:40:47.459963+11:00","panel_name":"Pituitary Tumour","panel_id":4364,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: sdhc has been classified as Green List (High Evidence).","entity_name":"SDHC","entity_type":"gene"},{"created":"2024-10-09T14:39:51.171703+11:00","panel_name":"Pituitary Tumour","panel_id":4364,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SDHB as ready","entity_name":"SDHB","entity_type":"gene"},{"created":"2024-10-09T14:39:51.152083+11:00","panel_name":"Pituitary Tumour","panel_id":4364,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: sdhb has been classified as Green List (High Evidence).","entity_name":"SDHB","entity_type":"gene"},{"created":"2024-10-09T14:38:53.178502+11:00","panel_name":"Pituitary Tumour","panel_id":4364,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SDHA as ready","entity_name":"SDHA","entity_type":"gene"},{"created":"2024-10-09T14:38:53.164955+11:00","panel_name":"Pituitary Tumour","panel_id":4364,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: sdha has been classified as Green List (High Evidence).","entity_name":"SDHA","entity_type":"gene"},{"created":"2024-10-09T14:35:47.422127+11:00","panel_name":"Pituitary Tumour","panel_id":4364,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PRKAR1A as ready","entity_name":"PRKAR1A","entity_type":"gene"},{"created":"2024-10-09T14:35:47.406657+11:00","panel_name":"Pituitary Tumour","panel_id":4364,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: prkar1a has been classified as Green List (High Evidence).","entity_name":"PRKAR1A","entity_type":"gene"},{"created":"2024-10-09T14:35:41.331991+11:00","panel_name":"Pituitary Tumour","panel_id":4364,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MEN1 as ready","entity_name":"MEN1","entity_type":"gene"},{"created":"2024-10-09T14:35:41.320255+11:00","panel_name":"Pituitary Tumour","panel_id":4364,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: men1 has been classified as Green List (High Evidence).","entity_name":"MEN1","entity_type":"gene"},{"created":"2024-10-09T14:35:34.842688+11:00","panel_name":"Pituitary Tumour","panel_id":4364,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CDKN1B as ready","entity_name":"CDKN1B","entity_type":"gene"},{"created":"2024-10-09T14:35:34.826366+11:00","panel_name":"Pituitary Tumour","panel_id":4364,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cdkn1b has been classified as Green List (High Evidence).","entity_name":"CDKN1B","entity_type":"gene"},{"created":"2024-10-09T14:35:25.671036+11:00","panel_name":"Pituitary Tumour","panel_id":4364,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: AIP as ready","entity_name":"AIP","entity_type":"gene"},{"created":"2024-10-09T14:35:25.651308+11:00","panel_name":"Pituitary Tumour","panel_id":4364,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: aip has been classified as Green List (High Evidence).","entity_name":"AIP","entity_type":"gene"},{"created":"2024-10-09T14:34:59.346185+11:00","panel_name":"Prostate Cancer","panel_id":4372,"panel_version":"1.0","user_name":"Zornitza Stark","item_type":"panel","text":"promoted panel to version 1.0","entity_name":null,"entity_type":null},{"created":"2024-10-09T14:34:41.613161+11:00","panel_name":"Prostate Cancer","panel_id":4372,"panel_version":"0.25","user_name":"Zornitza Stark","item_type":"panel","text":"Panel status changed from internal to public","entity_name":null,"entity_type":null},{"created":"2024-10-09T14:34:29.062258+11:00","panel_name":"Prostate Cancer","panel_id":4372,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TP53 as ready","entity_name":"TP53","entity_type":"gene"},{"created":"2024-10-09T14:34:29.038159+11:00","panel_name":"Prostate Cancer","panel_id":4372,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tp53 has been classified as Green List (High Evidence).","entity_name":"TP53","entity_type":"gene"},{"created":"2024-10-09T14:34:21.256572+11:00","panel_name":"Prostate Cancer","panel_id":4372,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PMS2 as ready","entity_name":"PMS2","entity_type":"gene"},{"created":"2024-10-09T14:34:21.236306+11:00","panel_name":"Prostate Cancer","panel_id":4372,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pms2 has been classified as Green List (High Evidence).","entity_name":"PMS2","entity_type":"gene"},{"created":"2024-10-09T14:34:15.439584+11:00","panel_name":"Prostate Cancer","panel_id":4372,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PALB2 as ready","entity_name":"PALB2","entity_type":"gene"},{"created":"2024-10-09T14:34:15.405267+11:00","panel_name":"Prostate Cancer","panel_id":4372,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: palb2 has been classified as Green List (High Evidence).","entity_name":"PALB2","entity_type":"gene"},{"created":"2024-10-09T14:34:08.382296+11:00","panel_name":"Prostate Cancer","panel_id":4372,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MSH6 as ready","entity_name":"MSH6","entity_type":"gene"},{"created":"2024-10-09T14:34:08.355432+11:00","panel_name":"Prostate Cancer","panel_id":4372,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: msh6 has been classified as Green List (High Evidence).","entity_name":"MSH6","entity_type":"gene"},{"created":"2024-10-09T14:34:02.436594+11:00","panel_name":"Prostate Cancer","panel_id":4372,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MSH2 as ready","entity_name":"MSH2","entity_type":"gene"},{"created":"2024-10-09T14:34:02.410361+11:00","panel_name":"Prostate Cancer","panel_id":4372,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: msh2 has been classified as Green List (High Evidence).","entity_name":"MSH2","entity_type":"gene"},{"created":"2024-10-09T14:33:56.839900+11:00","panel_name":"Prostate Cancer","panel_id":4372,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MLH1 as ready","entity_name":"MLH1","entity_type":"gene"},{"created":"2024-10-09T14:33:56.820906+11:00","panel_name":"Prostate Cancer","panel_id":4372,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mlh1 has been classified as Green List (High Evidence).","entity_name":"MLH1","entity_type":"gene"},{"created":"2024-10-09T14:33:47.086821+11:00","panel_name":"Prostate Cancer","panel_id":4372,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HOXB13 as ready","entity_name":"HOXB13","entity_type":"gene"},{"created":"2024-10-09T14:33:47.063662+11:00","panel_name":"Prostate Cancer","panel_id":4372,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hoxb13 has been classified as Green List (High Evidence).","entity_name":"HOXB13","entity_type":"gene"},{"created":"2024-10-09T14:33:40.226883+11:00","panel_name":"Prostate Cancer","panel_id":4372,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: EPCAM as ready","entity_name":"EPCAM","entity_type":"gene"},{"created":"2024-10-09T14:33:40.210951+11:00","panel_name":"Prostate Cancer","panel_id":4372,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: epcam has been classified as Green List (High Evidence).","entity_name":"EPCAM","entity_type":"gene"},{"created":"2024-10-09T14:33:34.108632+11:00","panel_name":"Prostate Cancer","panel_id":4372,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CHEK2 as ready","entity_name":"CHEK2","entity_type":"gene"},{"created":"2024-10-09T14:33:34.084663+11:00","panel_name":"Prostate Cancer","panel_id":4372,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: chek2 has been classified as Green List (High Evidence).","entity_name":"CHEK2","entity_type":"gene"}]}